<DOC>
	<DOCNO>NCT02079038</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness , measure change pain , disability , patient satisfaction , claudicatory symptom , 6 month follow treatment Totalis™ Direct Decompression System Sham Surgery patient lumbar spinal stenosis</brief_summary>
	<brief_title>The STEPS - Totalis™ Trial</brief_title>
	<detailed_description>Subjects suffer symptom neurogenic intermittent claudication secondary radiographically-confirmed diagnosis central canal stenosis , without mild moderate lateral recess stenosis , one two level L1 L5 meet inclusion/exclusion criterion , include ≥6 month non-operative management . Patients include clinical investigation return follow-up visit 1 week safety evaluation , 6 week , 3 month , 6 month , 12 month , 18 month 24 month post-treatment collect data evaluation safety effectiveness .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Spinal Stenosis</mesh_term>
	<criteria>Male female subject great equal 55 year age Neurogenic intermittent claudication ( NIC ) symptom define generally leg/buttock/ groin pain and/or paresthesia exacerbate stand walk relieve flexion VAS leg symptom severity &gt; 50 ( either leg ) episodes neurogenic claudication Subjects able walk minimum 50 foot without experience NIC symptom Diagnosis central canal spinal stenosis , without mild moderate lateral recess stenosis , one two level L1L5 radiologic evidence Subjects persistent lumbar spinal stenosis symptom , course last year , unresponsive minimum 6 month conservative therapy Significant back , buttock leg pain cause lumbar central canal stenosis Axial back pain Severe foraminal stenosis index level ( ) and/or symptomatic foraminal stenosis lumbar level Severe lateral recess stenosis Lumbar spinal stenosis two level determine preoperatively require surgical intervention Prior decompressive surgery index level ( ) fusion lumbar level Epidural steroid nerve block steroid injection index level ( ) within 6 week baseline assessment Spondylolisthesis ( anterolisthesis retrolisthesis ) great grade 1 Spondylolysis ( par fracture ) Significant degenerative lumbar scoliosis index level ( ) Morbid obesity Significant peripheral vascular disease Active significant comorbidity Undergoing immunosuppressive therapy longterm steroid use Current spinal cord stimulator implant pain pump Life expectancy le 2 year Evidence substance abuse within year Involvement potential involvement litigation relate spine worker 's compensation relate back and/or leg issue</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>